[Press Alert] Xenothera obtains authorization from ANSM to start the clinical trial of XAV-19, its anti Covid treatment

[Press Alert] Xenothera obtains authorization from ANSM to start the clinical trial of XAV-19, its anti Covid treatment

August 10, 2020.

# Download our press release (english version)

# Télécharger le communiqué (version française)